ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Merus NV

Merus NV (2GH)

41.40
0.00
( 0.00% )
Updated: 01:32:04
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
41.40
Bid
41.00
Ask
41.80
Volume
0.00
0.00 Day's Range 0.00
21.40 52 Week Range 58.50
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen aus...

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-4.1666666666743.2474319244.19451697DE
4-8.6-17.25051.540.411744.74603537DE
12-3.8-8.4070796460245.251.540.412747.17167127DE
26-6.8-14.107883817448.257.540.415948.57608533DE
5218.4802358.521.39999917344.34418355DE
15617.673.949579831923.858.51916742.00023485DE
26017.673.949579831923.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TE9Teco 2030 ASA
0.056 €
(56.42%)
885.27k
70ULion Electric Co The
0.4214 €
(32.27%)
15.65k
C62Chariot Limited
0.031 €
(29.17%)
3.5k
EJ7Energy Resources of Australia
0.0025 €
(25.00%)
188.5k
A6NAsana Inc
18.20 €
(24.66%)
2.7k
AXIAtos SE
0.003 €
(-98.48%)
847.72M
W47Grid Battery Metals Inc
0.0115 €
(-39.47%)
7
3RITurmalina Metals Corp
0.0156 €
(-38.58%)
3.8k
47GAGo Metals Corp
0.0202 €
(-36.88%)
3.44k
4APApollo Minerals Ltd
0.0055 €
(-35.29%)
270.7k
AXIAtos SE
0.003 €
(-98.48%)
847.72M
D7GNel ASA
0.2632 €
(-1.42%)
1.93M
TUI1Tui AG
8.434 €
(1.52%)
1.62M
TE9Teco 2030 ASA
0.056 €
(56.42%)
885.27k
LHADeutsche Lufthansa AG
6.698 €
(1.98%)
722.63k

Discussion

View Full Feed
silvr_surfr silvr_surfr 1 minute ago
... Maybe this is why CGON's stock price took a dump yesterday despite the strong readout on the Phase 3 results.
CGON
ddls ddls 2 minutes ago
My, that's quite a worthless resume, and all that worthless time spent trying to prop up this worthless company.😎
BIEL
georgie18 georgie18 3 minutes ago
yw...🥳
bio33 bio33 3 minutes ago
yep
well expected.....now we know who pulls the strings on AA with
no question....AA removed all doubt!!!!!!!!!!!!!!!!!!!!
just another criminal....this is well beyond the debt issue!!!!!!!!
AMC
Natural Trader Natural Trader 4 minutes ago
$ADD profit in thnx for the alert
ADD
Debunkinator Debunkinator 4 minutes ago
Light the fuse $ASII we are strapped in and ready🚀 💯
ASII
TRAPPER JIM TRAPPER JIM 4 minutes ago
I still have to get my fingerprints done and a background check. Then retake my hazardous materials test before I can renew my license in February 
jackson73 jackson73 5 minutes ago
Agreed thx G
glenn1919 glenn1919 5 minutes ago
BLDP.....GXAI.......https://stockcharts.com/h-sc/ui?s=GXAI&p=D&yr=0&mn=2&dy=12&id=p84071410134
BLDP GXAI
Remember Tomorrow Remember Tomorrow 5 minutes ago
Solid post.

RT
XRPUSD
Alpha14 Alpha14 5 minutes ago
Wait what?.... he needs to just get current and fix the SS... that's to start.
RNVA
navycmdr navycmdr 5 minutes ago
DOGE boys are on the JOB to WIPE OUT the Bloated FHFA salaries

Federal Housing Finance Agency (FHFA) Employee Salaries

The avg employee salary for the FHFA in 2023 was $183,288.

This is 155.5 percent higher than the national average for gov employees
FNMA
ktcougar ktcougar 6 minutes ago
3 month chart is looking good! I have high hopes for this one!
www.stockscores.com/chart.asp?TickerSymbol=ATOM&TimeRange=90&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=
ATOM
nowwhat2 nowwhat2 6 minutes ago
Dogecoin, etc.

https://investorshub.advfn.com/uimage/uploads/2024/12/6/nsulnbtc_121212_6_4am_GHOST_TREND_Q.jpg


https://investorshub.advfn.com/uimage/uploads/2024/12/6/pkibgbtc_121212_6_4am_STORM_Q.jpg__w_DOGE.jpg



How long will it B
DOGEUSD
Jake731 Jake731 6 minutes ago
Good morning all.






TPTW……!!!!!!!!!
TPTW
Invest-in-America Invest-in-America 7 minutes ago
ALBT: Soaring in the Pre-M. (Can't find any reasons for such, upon cursory search.)
ALBT
marcis marcis 7 minutes ago
LOL Chiron
Yes agree, to the buying part. 😎

Here we are in one of those one morning we wake up and a zero is missing off the SP

This is a sit back and look at something else stocks
The urge to flip is great I know, but did you see the last 10 minut
RDAR
glenn1919 glenn1919 7 minutes ago
BBAI.....QBTS......CHPT........https://stockcharts.com/h-sc/ui?s=BBAI&p=D&yr=0&mn=2&dy=12&id=p84071410134
BBAI CHPT QBTS
trainer2 trainer2 8 minutes ago
KBLB operations has too have a sustainable supply of silk to meet initial orders and then reorders of SELECTED initial customers.
Getting to this minimum supply of silk is underway.
KBLB
Zorch305 Zorch305 8 minutes ago
Right on Go $RNVA!!
RNVA
glenn1919 glenn1919 8 minutes ago
RCAT.......NVTS........SATL.........................................https://stockcharts.com/h-sc/ui?s=RCAT&p=D&yr=0&mn=2&dy=12&id=p84071410134
NVTS RCAT SATL
georgie18 georgie18 9 minutes ago
FYI...R/S coming here...🥳but great for a trade...

NEW YORK, NY and SÃO PAULO, BRAZIL / ACCESSWIRE / December 6, 2024 / SMX (Security Matters) PLC (NASDAQ:SMX)(NASDAQ:SMXWW), a pioneer in digitizing physical objects for circular economies, and Ybyra Capital (B3:YBRA4), an emerg
SMX
glenn1919 glenn1919 9 minutes ago
RGTI......MULN........https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
MULN RGTI
GBR GBR 9 minutes ago
That PR yesterday concerning Sense and Broadbean

Why no quote from Veritone in that PR.

Veritone hasn't even bothered to post about it on Linkedin. Sense posted about it on Linkedin, and they have 80k followers. Veritone could have at least reposted Sense's post.
VERI
StayHumble StayHumble 10 minutes ago
💹wow 2 BILLION+💹 Xpert BUYS💹wow💹💹💹https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/historical
HMBL

Your Recent History

Delayed Upgrade Clock